Usnoflast

DB18184InvestigationalSmall molecule

Usnoflast: Overview.

Mechanism: Pharmacologically active on NACHT, LRR and PYD domains-containing protein 3
Curator reviewed
Formula / weight: C₂₁H₂₉N₃O₃S · 403.54 g/mol (avg)
Code names: ZYIL-1

Resolves to

Compound

Structure

InChIKeyHAMGPBKPACGWND-ZOXUKVPXSA-NSMILESCN1CCC[C@]1(C)\C=C\S(=O)(=O)NC(=O)NC1=C2CCCC2=CC2=C1CCC2

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Usnoflast, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.